Your browser doesn't support javascript.
loading
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model.
Merkx, Robin I J; Rijpkema, Mark; Franssen, Gerben M; Kip, Annemarie; Smeets, Bart; Morgenstern, Alfred; Bruchertseifer, Frank; Yan, Eddie; Wheatcroft, Michael P; Oosterwijk, Egbert; Mulders, Peter F A; Heskamp, Sandra.
Afiliação
  • Merkx RIJ; Department of Medical Imaging, Nuclear Medicine, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Rijpkema M; Department of Urology, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Franssen GM; Department of Medical Imaging, Nuclear Medicine, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Kip A; Department of Medical Imaging, Nuclear Medicine, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Smeets B; Department of Medical Imaging, Nuclear Medicine, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Morgenstern A; Department of Pathology, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Bruchertseifer F; European Commission, Joint Research Centre (JRC), 76344 Karlsruhe, Germany.
  • Yan E; European Commission, Joint Research Centre (JRC), 76344 Karlsruhe, Germany.
  • Wheatcroft MP; Telix Pharmaceuticals Limited, Melbourne, VIC 3051, Australia.
  • Oosterwijk E; Telix Pharmaceuticals Limited, Melbourne, VIC 3051, Australia.
  • Mulders PFA; Department of Urology, Radboudumc, 6525 Nijmegen, The Netherlands.
  • Heskamp S; Department of Urology, Radboudumc, 6525 Nijmegen, The Netherlands.
Pharmaceuticals (Basel) ; 15(5)2022 May 02.
Article em En | MEDLINE | ID: mdl-35631396

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article